Xia Yan, DiPrimio Nina, Keppel Theodore R, Vo Binh, Fraser Keith, Battaile Kevin P, Egan Chet, Bystroff Christopher, Lovell Scott, Weis David D, Anderson J Christopher, Karanicolas John
Department of Molecular Biosciences, ‡Department of Chemistry, §Protein Structure Laboratory, and ∥Center for Bioinformatics, University of Kansas , Lawrence, Kansas 66045, United States.
J Am Chem Soc. 2013 Dec 18;135(50):18840-9. doi: 10.1021/ja407644b. Epub 2013 Dec 6.
The ability to selectively activate function of particular proteins via pharmacological agents is a longstanding goal in chemical biology. Recently, we reported an approach for designing a de novo allosteric effector site directly into the catalytic domain of an enzyme. This approach is distinct from traditional chemical rescue of enzymes in that it relies on disruption and restoration of structure, rather than active site chemistry, as a means to achieve modulate function. However, rationally identifying analogous de novo binding sites in other enzymes represents a key challenge for extending this approach to introduce allosteric control into other enzymes. Here we show that mutation sites leading to protein inactivation via tryptophan-to-glycine substitution and allowing (partial) reactivation by the subsequent addition of indole are remarkably frequent. Through a suite of methods including a cell-based reporter assay, computational structure prediction and energetic analysis, fluorescence studies, enzymology, pulse proteolysis, X-ray crystallography, and hydrogen-deuterium mass spectrometry, we find that these switchable proteins are most commonly modulated indirectly, through control of protein stability. Addition of indole in these cases rescues activity not by reverting a discrete conformational change, as we had observed in the sole previously reported example, but rather rescues activity by restoring protein stability. This important finding will dramatically impact the design of future switches and sensors built by this approach, since evaluating stability differences associated with cavity-forming mutations is a far more tractable task than predicting allosteric conformational changes. By analogy to natural signaling systems, the insights from this study further raise the exciting prospect of modulating stability to design optimal recognition properties into future de novo switches and sensors built through chemical rescue of structure.
通过药物试剂选择性激活特定蛋白质功能的能力是化学生物学中一个长期的目标。最近,我们报道了一种直接在酶的催化结构域中设计全新变构效应位点的方法。这种方法与传统的酶化学拯救方法不同,它依赖于结构的破坏和恢复,而不是活性位点化学,以此作为调节功能的手段。然而,合理识别其他酶中的类似全新结合位点是将这种方法扩展到其他酶以引入变构控制的关键挑战。在这里,我们表明,通过色氨酸到甘氨酸的取代导致蛋白质失活并通过随后添加吲哚允许(部分)重新激活的突变位点非常常见。通过一系列方法,包括基于细胞的报告基因检测、计算结构预测和能量分析、荧光研究、酶学、脉冲蛋白水解、X射线晶体学和氢-氘质谱分析,我们发现这些可切换蛋白质最常通过控制蛋白质稳定性间接调节。在这些情况下,添加吲哚恢复活性不是像我们在之前唯一报道的例子中观察到的那样通过恢复离散的构象变化,而是通过恢复蛋白质稳定性来恢复活性。这一重要发现将极大地影响未来通过这种方法构建的开关和传感器的设计,因为评估与形成空腔的突变相关的稳定性差异比预测变构构象变化要容易得多。类似于天然信号系统,这项研究的见解进一步提出了通过调节稳定性来为未来通过结构化学拯救构建的全新开关和传感器设计最佳识别特性的令人兴奋的前景。